Regulations.gov document
Determination of Regulatory Review Period for Purposes of Patent Extension; Nuzyra Tablets…
Notice · FDA-2019-E-5267 · posted Dec 8, 2023
Key facts
| Document ID | FDA-2019-E-5267-0004 |
|---|---|
| Title | Determination of Regulatory Review Period for Purposes of Patent Extension; Nuzyra Tablets (New Drug Application 209816) |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2019-E-5267 |
| Posted | Dec 8, 2023 |
| Federal Register citation | 88 FR 85643 |
| FR document number | 2023-26989 |
| Comment period opens | Dec 8, 2023 |
| Comments due | Feb 7, 2024 |
| Effective date | Dec 8, 2023 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: